Idiopathic Pulmonary Fibrosis
Symptoms, Doctors, Treatments, Advances & More

Learn About Idiopathic Pulmonary Fibrosis

What is the definition of Idiopathic Pulmonary Fibrosis?

Idiopathic pulmonary fibrosis (IPF) is scarring or thickening of the lungs without a known cause.

What are the alternative names for Idiopathic Pulmonary Fibrosis?

Idiopathic diffuse interstitial pulmonary fibrosis; IPF; Pulmonary fibrosis; Cryptogenic fibrosing alveolitis; CFA; Fibrosing alveolitis; Usual interstitial pneumonitis; UIP

What are the causes of Idiopathic Pulmonary Fibrosis?

Health care providers do not know what causes IPF or why some people develop it. Idiopathic means the cause is not known. The condition may be due to the lungs responding to an unknown substance or injury. Genes may play a role in developing IPF. The disease occurs most often in people between 60 and 70 years old. IPF is more common in men than women.

What are the symptoms of Idiopathic Pulmonary Fibrosis?

When you have IPF, your lungs become scarred and stiffened. This eventually makes it hard for you to breathe. In most people, IPF gets worse quickly over months or a few years. In others, IPF worsens over a much longer time.

Symptoms may include any of the following:

  • Chest pain (sometimes)
  • Cough (usually dry)
  • Not able to be as active as before
  • Shortness of breath during activity (this symptom lasts for months or years, and over time may also occur when at rest)
  • Feeling faint
  • Gradual weight loss
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Idiopathic Pulmonary Fibrosis?

There is no known cure for IPF.

Treatment is aimed at relieving symptoms and slowing disease progression:

  • Pirfenidone (Esbriet), nintedanib (Ofev), and nerandomilast (Jascayd) are medicines that are used to treat people with IPF. They help slow lung damage but do not reverse damage that has already occurred.
  • People with low blood oxygen levels benefit from supplemental oxygen.
  • Lung rehabilitation will not cure the disease, but it can help people exercise with less difficulty breathing.

Making home and lifestyle changes can help manage breathing symptoms. If you or any family members smoke, now is the time to stop.

A lung transplant is an option for some people with pulmonary fibrosis.

Who are the top Idiopathic Pulmonary Fibrosis Local Doctors?
Elite in Idiopathic Pulmonary Fibrosis
Pulmonary Medicine
Elite in Idiopathic Pulmonary Fibrosis
Pulmonary Medicine
Referral may be required

Interstitial Lung Disease (ILD) Program

400 Parnassus Ave., Sixth Floor, Room A6114, 
San Francisco, CA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Paul Wolters is a Pulmonary Medicine provider practicing medicine in San Francisco, California. Dr. Wolters is rated as an Elite provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Pulmonary Fibrosis, and Lung Transplant. Dr. Wolters is board certified in American Board Of Internal Med/Critical Care Med, Critical Care Medicine and American Board Of Internal Med/Pulmonary Disease, Pulmonary Disease. Dr. Wolters is currently accepting new patients.

Elite in Idiopathic Pulmonary Fibrosis
Pulmonary Medicine
Elite in Idiopathic Pulmonary Fibrosis
Pulmonary Medicine
Referral may be required

UVA Health Culpeper Medical Center

501 Sunset Ln, 
Culpeper, VA 
Languages Spoken:
English, Hebrew
Accepting New Patients
Offers Telehealth

Imre Noth is a Pulmonary Medicine provider practicing medicine in Culpeper, Virginia. Dr. Noth is rated as an Elite provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Acute Interstitial Pneumonia, Lung Transplant, and Gastrostomy. Dr. Noth is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Idiopathic Pulmonary Fibrosis
Pulmonary Medicine
Elite in Idiopathic Pulmonary Fibrosis
Pulmonary Medicine
Referral may be required

San Francisco Medical Center

2350 Geary Blvd, 1st Floor, 
San Francisco, CA 
Languages Spoken:
English
Accepting New Patients

Brett Ley is a Pulmonary Medicine provider practicing medicine in San Francisco, California. Dr. Ley is rated as an Elite provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Interstitial Lung Disease, and Lung Transplant. Dr. Ley is currently accepting new patients.

What are the support groups for Idiopathic Pulmonary Fibrosis?

You can ease the stress of illness by joining a support group. Sharing with others who have common experiences and problems can help you not feel alone.

More information and support for people with IPF and their families can be found at:

  • Pulmonary Fibrosis Foundation -- www.pulmonaryfibrosis.org/patients-caregivers/medical-and-support-resources/find-a-support-group
  • American Lung Association -- www.lung.org/help-support/better-breathers-club
What is the outlook (prognosis) for Idiopathic Pulmonary Fibrosis?

IPF may improve or stay stable for a long time with or without treatment. Most people get worse, even with treatment.

When breathing symptoms become more severe, you and your provider should discuss treatments that prolong life, such as lung transplantation. Also discuss advance care planning.

What are the possible complications of Idiopathic Pulmonary Fibrosis?

Complications of IPF may include:

  • Abnormally high levels of red blood cells due to low blood oxygen levels
  • Collapsed lung
  • High blood pressure in the arteries of the lungs
  • Respiratory failure
  • Cor pulmonale (right-sided heart failure)
  • Death
When should I contact a medical professional for Idiopathic Pulmonary Fibrosis?

Contact your provider right away if you have any of the following:

  • Breathing that is harder, faster, or shallower (you are unable to take a deep breath)
  • Need to lean forward when sitting to breathe comfortably
  • Frequent headaches
  • Sleepiness or confusion
  • Fever
  • Dark mucus when you cough
  • Blue fingertips or skin around your fingernails
What are the latest Idiopathic Pulmonary Fibrosis Clinical Trials?
‌‌‌‌‌
‌‌‌‌
Match to trials
Find the right clinical trials for you in under a minute
Get started
‌‌‌‌‌
‌‌‌‌
Who are the sources who wrote this article ?

Published Date: May 04, 2026
Published By: Andrew Schriber, MD, FCCP, Specialist in Pulmonary, Critical Care, and Sleep Medicine, Virtua Memorial Hospital, Mount Holly, New Jersey. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

National Heart, Lung, and Blood Institute website. What is idiopathic pulmonary fibrosis? www.nhlbi.nih.gov/health/idiopathic-pulmonary-fibrosis. Updated June 26, 2023. Accessed June 10, 2026.

Raghu G, Martinez FJ. Interstitial lung disease. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 80.

Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205(9):e18-e47. PMID: 35486072 pubmed.ncbi.nlm.nih.gov/35486072/.

Ryu JH, Selman M, Lee JS, Colby TV, King TE. Idiopathic pulmonary fibrosis. In: Broaddus VC, Ernst JD, King TE, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 7th ed. Philadelphia, PA: Elsevier; 2022:chap 89.

Silhan LL, Danoff SK. Nonpharmacologic therapy for idiopathic pulmonary fibrosis. In: Collard HR, Richeldi L, eds. Interstitial Lung Disease. Philadelphia, PA: Elsevier; 2018:chap 5.